Posted on

GDMEDS STRENGTHENS THE TEAM OF CHEMIST/PHARMACIST TO SERVE BETTER…..

Posted on

With rising health care costs and the advent of consumer-driven health care, consumers now take a more active role in the health care process and their health care decisions. Smart consumers look for medical providers and health care centers that offer comprehensive health services. Pharmacies and medical retail clinics, and the retail pharmacists serve as…

Read more

Posted on

THANKS GOOGLE TRANSLATORS…….

Posted on

Thanks, Google translator Gracias traductor de google Merci, traducteur Google 谢谢,谷歌翻译 マイレビュー спасибо, гугл-переводчик 감사,구글 번역기 cảm ơn, google translator danke, google übersetzer GDMeds leading online pharmaceutical company has a support hand ofGoogle translators for their well growth in their business. Google translators are a free multilingual machine translation service developed byGoogle, to translate text.…

Read more

Posted on

Recent Immunotherapy Treatments for Metastatic Breast Cancer.

Posted on

  For some cancers such as melanoma and leukemia, immunotherapy has produced responses so durable that there is hope for the possibility of a cure in an increasing proportion of patients. In recent years, these novel therapies have also demonstrated efficacy in battling metastatic breast cancer. “Breast cancer may not respond as well to immunotherapy…

Read more

Posted on

GDMEDS OPENING SHORTLY CUSTOMER SERVICE CENTRE IN GODS OWN COUNTRY- KERALA.

Posted on

GDMeds one of the leading online pharmacy has released fantastic news as they are going to build up their strength in Kerala. GDMeds was started by the intention of Dr.Liya and Vincent Cooper to help patients purchase reliable and cheap generic anti-cancer medicines since 2014, they started up their business as a ground level business…

Read more

Posted on Leave a comment

FDA Approves Two-Drug Combo Mavyret for HCV in Adolescents.

Posted on Leave a comment

The US Food and Drug Administration (FDA) approved glecaprevir and pibrentasvir (Mavyret, AbbVie) tablets for the treatment of all six hepatitis C virus (HCV) genotypes in children ages 12 to 17 years. The FDA approved the drug combination for adults with all six genotypes of hepatitis C on Aug. 3, 2017. “Direct-acting antiviral drugs reduce the amount of HCV in the…

Read more

Posted on Leave a comment

Finding the ‘Sweet Spot’ With Corticosteroids in Cancer Care.

Posted on Leave a comment

Mark Kris from Memorial Sloan Kettering, speaking again about the use of corticosteroids in oncology. Clearly, they’re one of our go-to agents, part of our standard antiemetic regimens, a cornerstone of the management of neurologic complications, and part of the management of many side effects, including dyspnea and anorexia. It’s very important to use corticosteroids…

Read more

Posted on Leave a comment

Newly Approved Osteoporosis Drug Is ‘Promising’ and ‘Welcome’

Posted on Leave a comment

  In medicine, lessons from rare genetic disorders can sometimes be turned into treatment for a common disease. Since the discovery that patients with sclerostin deficiency have surprisingly high bone mass,[1,2,3] inhibiting sclerostin has been an appealing strategy to treat osteoporosis. Romosozumab is a humanized monoclonal antibody against sclerostin, and its approval by the US Food and Drug Administration…

Read more